Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Found 5682 publications
Treventis Corporation - Product Pipeline Review - 2014 US$ 1,500.00

... and its locations and subsidiaries The report reviews current pipeline of Treventis Corporation’s human therapeutic division and enlists all their major ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Treventis Corporation’s pipeline products ...

Aug, 2014 22 pages
Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... Markets Direct’s, ‘Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014’, provides an overview of the Sol-Gel Technologies Ltd.’s pharmaceutical research ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Sol-Gel Technologies Ltd.’s pipeline ...

Aug, 2014 18 pages
NeoPharm Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of NeoPharm Co., Ltd.’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the NeoPharm Co., Ltd.’s pipeline products ...

Aug, 2014 31 pages
Molecular Templates Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Molecular Templates Inc.’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Molecular Templates Inc.’s pipeline products Reasons to ...

Aug, 2014 29 pages
Intezyne, Inc - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Intezyne, Inc’s pipeline products ... drug targets and therapeutic classes in the Intezyne, Inc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 27 pages
EyeCyte, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the EyeCyte, Inc.’s pipeline products ... drug targets and therapeutic classes in the EyeCyte, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 20 pages
Da Volterra - Product Pipeline Review - 2014 US$ 1,500.00

Summary Global Markets Direct’s, ‘Da Volterra - Product Pipeline Review - 2014’, provides an overview of the Da Volterra’s pharmaceutical research and development focus. This ... and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key ...

Aug, 2014 21 pages
CYATHUS EXQUIRERE PharmaforschungsGmbH - Product Pipeline Review - 2014 US$ 1,500.00

... (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the CYATHUS EXQUIRERE PharmaforschungsGmbH’s pipeline products Reasons ...

Aug, 2014 17 pages
AllTranz, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AllTranz, Inc.’s pipeline products ... drug targets and therapeutic classes in the AllTranz, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 21 pages
vasopharm GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the vasopharm GmbH’s pipeline products ... drug targets and therapeutic classes in the vasopharm GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 22 pages
Tacere Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Tacere Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Tacere Therapeutics, Inc.’s pipeline products Reasons to ...

Jul, 2014 27 pages
Phenomenome Discoveries, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Phenomenome Discoveries, Inc.’s pipeline products Reasons ... Assess the growth potential of Phenomenome Discoveries, Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the ...

Jul, 2014 20 pages
Northern Antibiotics Oy - Product Pipeline Review - 2014 US$ 1,500.00

... its locations and subsidiaries The report reviews current pipeline of Northern Antibiotics Oy’s human therapeutic division and enlists all their major ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Northern Antibiotics Oy’s pipeline products ...

Aug, 2014 21 pages
Koronis Pharma, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Koronis Pharma, Inc.’s pipeline products Reasons to ... of focus Identify new drug targets and therapeutic classes in the Koronis Pharma, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce ...

Aug, 2014 24 pages
Haemostatix Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Haemostatix Ltd’s pipeline products ... drug targets and therapeutic classes in the Haemostatix Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 20 pages
Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Constellation Pharmaceuticals, Inc.’s pipeline products Reasons ...

Aug, 2014 20 pages
Cognosci, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Cognosci, Inc.’s pipeline products ... drug targets and therapeutic classes in the Cognosci, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 29 pages
CLL Pharma - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the CLL Pharma’s pipeline products ... new drug targets and therapeutic classes in the CLL Pharma’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 21 pages
ALSP, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the ALSP, Inc.’s pipeline products ... new drug targets and therapeutic classes in the ALSP, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 19 pages
Adiga Life Sciences Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Adiga Life Sciences Inc. including business description, key information and facts, and its ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Adiga Life Sciences Inc.’s pipeline products ...

Aug, 2014 16 pages
Umecrine Mood AB - Product Pipeline Review - 2014 US$ 1,500.00

... business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Umecrine Mood AB’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Umecrine Mood AB’s pipeline products ...

Jul, 2014 21 pages
Targazyme, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Targazyme, Inc.’s pipeline products ... drug targets and therapeutic classes in the Targazyme, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 20 pages
Pherecydes Pharma SA - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Pherecydes Pharma SA’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Pherecydes Pharma SA’s pipeline products ...

Jul, 2014 22 pages
Laboratorios Sophia S.A. de C.V. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Laboratorios Sophia S.A. de C.V.’s pipeline products ...

Jul, 2014 21 pages
Immune Targeting Systems (ITS) Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Immune Targeting Systems (ITS) Ltd.’s pipeline ... -licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Explore the ...

Jul, 2014 20 pages
Echo Pharmaceuticals B.V. - Product Pipeline Review - 2014 US$ 1,500.00

... report reviews current pipeline of Echo Pharmaceuticals B.V.’s human therapeutic division and enlists all their major and minor projects The report ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Echo Pharmaceuticals B.V.’s pipeline products ...

Jul, 2014 23 pages
Sun Pharmaceutical 2009-2014 US$ 995.00

... Partnering Agreements with Sun pharmaceutical 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds ... of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the ...

Aug, 2014 100 pages
Zhejiang Hisun Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Zhejiang Hisun Pharmaceutical Co., Ltd.’s pipeline products ...

Jul, 2014 29 pages
RuiYi Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the RuiYi Inc.’s pipeline products ... new drug targets and therapeutic classes in the RuiYi Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 26 pages
Provecs Medical GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Provecs Medical GmbH’s pipeline products Reasons ... of focus Identify new drug targets and therapeutic classes in the Provecs Medical GmbH’s R&D portfolio and develop key strategic initiatives to reinforce ...

Jul, 2014 19 pages
ProCertus BioPharm Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of ProCertus BioPharm Inc.’s human therapeutic ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the ProCertus BioPharm Inc.’s pipeline products Reasons ...

Jul, 2014 21 pages
Nerviano Medical Sciences - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Nerviano Medical Sciences ’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Nerviano Medical Sciences ’s pipeline products Reasons ...

Jul, 2014 52 pages
Navya Biologicals Pvt Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Navya Biologicals Pvt Ltd including business description, key information and facts, and its ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Navya Biologicals Pvt Ltd’s pipeline products ...

Jul, 2014 25 pages
Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Janssen Pharmaceuticals, Inc.’s pipeline products Reasons to ...

Jul, 2014 28 pages
CoMentis, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the CoMentis, Inc.’s pipeline products ... drug targets and therapeutic classes in the CoMentis, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 22 pages
CerRx, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the CerRx, Inc.’s pipeline products ... new drug targets and therapeutic classes in the CerRx, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 22 pages
BioCrea GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the biocrea GmbH’s pipeline products ... drug targets and therapeutic classes in the biocrea GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 26 pages
3-V Biosciences, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... and its locations and subsidiaries The report reviews current pipeline of 3-V Biosciences, Inc.’s human therapeutic division and enlists all their major ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the 3-V Biosciences, Inc.’s pipeline products ...

Jun, 2014 23 pages
SignPath Pharma Inc - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the SignPath Pharma Inc’s pipeline products Reasons to ... of focus Identify new drug targets and therapeutic classes in the SignPath Pharma Inc’s R&D portfolio and develop key strategic initiatives to reinforce ...

Jun, 2014 22 pages
Pharmicell Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Pharmicell Co., Ltd.’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Pharmicell Co., Ltd.’s pipeline products ...

Jul, 2014 32 pages
NuCana BioMed Limited - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the NuCana BioMed Limited’s pipeline products Reasons ... of focus Identify new drug targets and therapeutic classes in the NuCana BioMed Limited’s R&D portfolio and develop key strategic initiatives to reinforce ...

Jul, 2014 34 pages
Microbio Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Microbio Co., Ltd.’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Microbio Co., Ltd.’s pipeline products ...

Jul, 2014 28 pages
International Stem Cell Corporation - Product Pipeline Review - 2014 US$ 1,500.00

... . Scope The report provides brief overview of International Stem Cell Corporation including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the International Stem Cell Corporation’s pipeline products ...

Jun, 2014 20 pages
GNI Group Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the GNI Group Ltd.’s pipeline products Reasons to ...

Jun, 2014 26 pages
Ferring International Center S.A. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Ferring International Center S.A.’s pipeline products Reasons ...

Jul, 2014 46 pages
Phylogica Limited - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Phylogica Limited’s pipeline products ... areas of focus Identify new drug targets and therapeutic classes in the Phylogica Limited’s R&D portfolio and develop key strategic initiatives to reinforce ...

Jul, 2014 22 pages
Genexine, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Genexine, Inc.’s pipeline products ... drug targets and therapeutic classes in the Genexine, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 32 pages
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Dong Wha Pharma Co., Ltd. including business description, key information and facts, and its ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Dong Wha Pharma Co., Ltd.’s pipeline products ...

Jul, 2014 32 pages
Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014 US$ 2,000.00

... Dermatoses - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014’, provides an overview of the Corticosteroid-Responsive Dermatoses’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Jun, 2014 33 pages
SIFI S.p.A - Product Pipeline Review - 2014 US$ 1,500.00

... Summary Global Markets Direct’s, ‘SIFI S.p.A - Product Pipeline Review - 2014’, provides an overview of the SIFI S.p.A’s pharmaceutical research and development focus. This ... type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued ...

Jun, 2014 27 pages
1 2 3 4 5 >
Skip to top